Novartis eye care unit Alcon is voluntarily withdrawing its CyPass Micro-Stent after follow-up clinical data showed patients using the product experienced statistically significant endothelial cell loss compared with those who underwent cataract surgery alone.

https://ift.tt/2wlAyMe support@endlesssupplies.biz (Endless Supplies .Biz) August 29, 2018 at 01:02AM
No comments:
Post a Comment